Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05617365 · ClinicalTrials.gov registry record · Phase 1
Treating Chronic Cervicogenic Head and Neck Pain
A Phase 1 study of Cervicogenic Headache and Neck Pain, Posterior, sponsored by Michigan State University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05617365 is a Phase 1 study of Cervicogenic Headache and Neck Pain, Posterior that is actively recruiting participants, run by Michigan State University. The registered enrollment target is 30 participants, below the 63-participant average among 4 other Cervicogenic Headache trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05617365, a Phase 1 study of Cervicogenic Headache and Neck Pain, Posterior, is actively recruiting participants, sponsored by Michigan State University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim is to test the combined effectiveness of OMT and targeted head exercise (THE) to achieve a significant decrease in headache measures of frequency, intensity, and duration in a Treatment group when compared to a Control group whose members receive only standard medical care. A parallel, 2-arm, longitudinal, randomized controlled trial (RCT) will focus upon female patients (18 to 75 years of age) who have been diagnosed with chronic cervicogenic headache (CeH) based upon a differential diagnosis that includes classification according to the International Headache Society Classification IHSD 3rd Edition, reproduction of referred headache resulting from manual pressure over the upper cervical regions, and objective MRI findings. It is estimated that a sample size of 30 will provide sufficient statistical power (79%) to detect an intervention effect that corresponds to a clinically meaningful recovery (60%). CeH is classified as a secondary headache disorder because the headache pain is a consequence of injury to, or disease of, the bony and/or soft tissues of the upper cervical spine. It has been reported that some patients diagnosed with CeH demonstrate atrophy and/or fatty infiltration (FI) of the RCPm muscles on MRI. FI and/or a reduction in the cross-sectional area (CSA) of active muscle would not be expected to be the direct cause of chronic headache, but either or both could prevent muscles from generating normal physiologic levels of force. It has been shown that there is a functional connection between the pain sensitive dura mater and RCPm muscles and it is known that mechanical stretching of the dura mater results in referred headache. While FI and/or a reduction in the CSA of active muscle would not be expected to be the direct cause of chronic headache, it is known that muscle pathology will result in functional deficits. It is proposed that pathology in RCPm muscles will compromise the normal functional relationship between the RCPm and th
Conditions Studied
Interventions
- COMBINATION_PRODUCT Osteopathic Manipulative Therapy and Exercise Therapy
Study Locations (1)
Michigan
- Michigan State University - East Lansing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2026-06-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05617365
The ClinicalTrials.gov registry entry for NCT05617365 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 63-participant average among 4 other Cervicogenic Headache trials with a reported enrollment target (52% lower). The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cervicogenic Headache appearing as the primary indexed condition, and to 1 intervention - of which Osteopathic Manipulative Therapy and Exercise Therapy is the first listed.
NCT05617365 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT05617365 about?
NCT05617365 is a clinical study titled "Treating Chronic Cervicogenic Head and Neck Pain". The primary aim is to test the combined effectiveness of OMT and targeted head exercise (THE) to achieve a significant decrease in headache measures of frequency, intensity, and duration in a Treatment group when compared to a Control group whose members receive only standard medical care. A paralle...
What is the current status of trial NCT05617365?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2022-09-01. Estimated completion is 2026-06-01.
What conditions does trial NCT05617365 study?
This clinical trial studies the following conditions: Cervicogenic Headache, Neck Pain, Posterior.
What interventions are being tested in trial NCT05617365?
The interventions under investigation include: Osteopathic Manipulative Therapy and Exercise Therapy (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05617365?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05617365 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervicogenic Headache
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Manipulation and Dry Needling in Patients With Cervicogenic Headache and WAD II
RECRUITING · NA
-
The MONARCH Case Series Study: SPRINT® Peripheral Nerve Stimulation for the Treatment of Head Pain
ACTIVE NOT RECRUITING · NA
-
Mobilization Versus Manipulation for the Treatment of Cervicogenic Headaches
COMPLETED · NA
-
Ultrasound Greater Occipital Nerve Block at C2 Level Compared to Landmark-based Greater Occipital Nerve Block
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.